Clariane SE

EPA-CLARI
Euronext Paris
Healthcare Medical Care Facilities
Global Rank
#5742
Country Rank
#100
Market Cap
2.25 B
Price
6.23
Change (%)
0.94%
Volume
156,274

Clariane SE's latest marketcap:

2.25 B

As of 07/05/2025, Clariane SE's market capitalization has reached $2.25 B. According to our data, Clariane SE is the 5742th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.25 B
Revenue (ttm) 6.22 B
Net Income (ttm) -64,905,678.81
Shares Out 356.71 M
EPS (ttm) -0.28
Forward PE 18.11
Ex-Dividend Date n/a
Earnings Date 07/29/2025
Market Cap Chart
Data Updated: 07/05/2025

Clariane SE's yearly market capitalization.

Clariane SE has seen its market value drop from €2.39 B to €2.25 B since 2014, representing a total decrease of 5.62% and an annual compound decline rate (CAGR) of 0.55%.
Date Market Cap Change (%) Global Rank
07/05/2025 €2.25 B 157.26% 5742
12/31/2024 €743.19 M 189.51% 10238
12/29/2023 €256.7 M -75.97% 16795
12/30/2022 €1.07 B -63.65% 7626
12/31/2021 €2.94 B -10.72% 4385
12/31/2020 €3.29 B -5.07% 3361
12/31/2019 €3.47 B 36.11% 2871
12/31/2018 €2.55 B 6.86% 3093
12/29/2017 €2.38 B 6.83% 3597
12/30/2016 €2.23 B -16.61% 3522

Company Profile

About Clariane SE

Clariane SE is a leading provider of care home, healthcare facilities, and shared living solutions across Europe, including France, Germany, Benelux, Italy, Spain, and the United Kingdom.

Services Offered

  • Long-term & Short-stay Nursing Homes: Specialized care for elderly and patients requiring medical attention.
  • Healthcare Services: Includes medical and full hospitalization, day hospitalization, and outpatient consultations.
  • Post-Acute & Rehabilitation Care: Facilities dedicated to recovery and rehabilitation.
  • Mental Healthcare Clinics: Specialized support for mental health conditions.
  • Home & Community Nursing: Hospital home care networks and community-based nursing services.
  • Assisted Living & Shared Housing: Residences offering independent living with support.

Company Background

Originally founded in 2001 as Korian, the company rebranded to Clariane SE in June 2023. Headquartered in Paris, France, Clariane SE continues to expand its footprint in European healthcare and senior living solutions.

Frequently Asked Questions

  • What is Clariane SE's (EPA-CLARI) current market cap?
    As of 07/05/2025, Clariane SE (including the parent company, if applicable) has an estimated market capitalization of $2.25 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Clariane SE global market capitalization ranking is approximately 5742 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.